Quality of Life With Bone Conduction Hearing Device
Audiological Benefit and Improved Quality of Life in Patients With a Bone Conduction Device - a Randomized Controlled Trial
1 other identifier
interventional
24
1 country
1
Brief Summary
The aim of this study is to compare the audiological and quality of life performance patients have with an ADHEAR (adhesive bone conduction device) compared to no hearing device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2019
CompletedStudy Start
First participant enrolled
February 25, 2019
CompletedFirst Posted
Study publicly available on registry
March 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2024
CompletedMay 13, 2025
May 1, 2025
5.4 years
February 24, 2019
May 7, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
AQoL (Assessment of Quality of Life) Results
The primary objective of this study is to evaluate, whether patients using ADHEAR have a significantly improved quality of life compared to patients not fitted with a device with the AQoL (Assessment of Quality of Life) questionnaire. It comprises 35 questions covering a multitude of quality of life aspects. Weighted utilities are generated using the algorithms provided on the AQoL website. Weighted utilities give a number between 0 and 1 as answer for every question. These sub scores are then presented.
4 months
Study Arms (1)
Bone conduction device - ADHEAR
OTHERPatients will receive a hearing aid (ADHEAR). Hearing assessment will be carried out. Quality of life measurement will be carried out.
Interventions
Eligibility Criteria
You may qualify if:
- Unilateral and/or bilateral conductive hearing loss (CHL)
- Conductive hearing loss \>10 decibel on average
- Subjective benefit from the device
- Subjects aged 13 years or older
- Capable of the German language
- Willingness and ability to perform all tests required for the study
- Signed, and dated informed consent before the start of any study specific procedure
You may not qualify if:
- Pregnancy or breastfeeding
- Patient uses a hearing aid or plans to acquire a hearing aid
- Patient is intolerant of the materials as described by Manufacturer
- Patient presents with a skin or scalp condition that may preclude the attachment of the adhesive adapter.
- Patient cannot perform the audiological tests or is unable to fill out the questionnaires.
- Patient presents with retrocochlear, or central auditory disorder.
- any physical, psychological, or emotional disorder that would interfere with the ability to perform on test and rehabilitation procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MUW AKH
Vienna, 1090, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Valerie Dahm, MD
MUW
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 24, 2019
First Posted
March 6, 2019
Study Start
February 25, 2019
Primary Completion
July 31, 2024
Study Completion
October 31, 2024
Last Updated
May 13, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share